Global Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and remember it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

According to APO Research, The global Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Vaccines include GSK, Sanofi, Merck, Pfizer, Novartis(GSK), CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Vaccines sales, projected growth trends, production technology, application and end-user industry.


Vaccines Segment by Company

GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan

Vaccines Segment by Type

Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others

Vaccines Segment by Application

Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others

Vaccines Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Vaccines Market Size, 2020 VS 2024 VS 2031
1.3 Global Vaccines Market Size Estimates and Forecasts (2020-2031)
1.4 Global Vaccines Sales Estimates and Forecasts (2020-2031)
1.5 Global Vaccines Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Vaccines Market Dynamics
2.1 Vaccines Industry Trends
2.2 Vaccines Industry Drivers
2.3 Vaccines Industry Opportunities and Challenges
2.4 Vaccines Industry Restraints
3 Vaccines Market by Manufacturers
3.1 Global Vaccines Revenue by Manufacturers (2020-2025)
3.2 Global Vaccines Sales by Manufacturers (2020-2025)
3.3 Global Vaccines Average Sales Price by Manufacturers (2020-2025)
3.4 Global Vaccines Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Vaccines Manufacturers, Product Type & Application
3.7 Global Vaccines Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Vaccines Players Market Share by Revenue in 2024
3.8.3 2024 Vaccines Tier 1, Tier 2, and Tier 3
4 Vaccines Market by Type
4.1 Vaccines Type Introduction
4.1.1 Recombinant Vaccines
4.1.2 Viral Vaccines
4.1.3 Polysaccharide Vaccines
4.1.4 Others
4.2 Global Vaccines Sales by Type
4.2.1 Global Vaccines Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Vaccines Sales by Type (2020-2031)
4.2.3 Global Vaccines Sales Market Share by Type (2020-2031)
4.3 Global Vaccines Revenue by Type
4.3.1 Global Vaccines Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Vaccines Revenue by Type (2020-2031)
4.3.3 Global Vaccines Revenue Market Share by Type (2020-2031)
5 Vaccines Market by Application
5.1 Vaccines Application Introduction
5.1.1 Rabies vaccine
5.1.2 Influenza vaccine
5.1.3 HPV vaccine
5.1.4 Hepatitis B
5.1.5 Hepatitis A
5.1.6 Leprosy vaccine
5.1.7 Polio vaccine
5.1.8 JE vaccine
5.1.9 Others
5.2 Global Vaccines Sales by Application
5.2.1 Global Vaccines Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Vaccines Sales by Application (2020-2031)
5.2.3 Global Vaccines Sales Market Share by Application (2020-2031)
5.3 Global Vaccines Revenue by Application
5.3.1 Global Vaccines Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Vaccines Revenue by Application (2020-2031)
5.3.3 Global Vaccines Revenue Market Share by Application (2020-2031)
6 Global Vaccines Sales by Region
6.1 Global Vaccines Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Vaccines Sales by Region (2020-2031)
6.2.1 Global Vaccines Sales by Region (2020-2025)
6.2.2 Global Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Vaccines Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Vaccines Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Vaccines Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Vaccines Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Vaccines Revenue by Region
7.1 Global Vaccines Revenue by Region
7.1.1 Global Vaccines Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Vaccines Revenue by Region (2020-2025)
7.1.3 Global Vaccines Revenue by Region (2026-2031)
7.1.4 Global Vaccines Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Vaccines Revenue (2020-2031)
7.2.2 North America Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Vaccines Revenue (2020-2031)
7.3.2 Europe Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Vaccines Revenue (2020-2031)
7.4.2 Asia-Pacific Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Vaccines Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 GSK
8.1.1 GSK Comapny Information
8.1.2 GSK Business Overview
8.1.3 GSK Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 GSK Vaccines Product Portfolio
8.1.5 GSK Recent Developments
8.2 Sanofi
8.2.1 Sanofi Comapny Information
8.2.2 Sanofi Business Overview
8.2.3 Sanofi Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Sanofi Vaccines Product Portfolio
8.2.5 Sanofi Recent Developments
8.3 Merck
8.3.1 Merck Comapny Information
8.3.2 Merck Business Overview
8.3.3 Merck Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Merck Vaccines Product Portfolio
8.3.5 Merck Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Vaccines Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Novartis(GSK)
8.5.1 Novartis(GSK) Comapny Information
8.5.2 Novartis(GSK) Business Overview
8.5.3 Novartis(GSK) Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Novartis(GSK) Vaccines Product Portfolio
8.5.5 Novartis(GSK) Recent Developments
8.6 CSL
8.6.1 CSL Comapny Information
8.6.2 CSL Business Overview
8.6.3 CSL Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 CSL Vaccines Product Portfolio
8.6.5 CSL Recent Developments
8.7 MedImmune LLC
8.7.1 MedImmune LLC Comapny Information
8.7.2 MedImmune LLC Business Overview
8.7.3 MedImmune LLC Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 MedImmune LLC Vaccines Product Portfolio
8.7.5 MedImmune LLC Recent Developments
8.8 J&J(Crucell)
8.8.1 J&J(Crucell) Comapny Information
8.8.2 J&J(Crucell) Business Overview
8.8.3 J&J(Crucell) Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 J&J(Crucell) Vaccines Product Portfolio
8.8.5 J&J(Crucell) Recent Developments
8.9 China National Biotec
8.9.1 China National Biotec Comapny Information
8.9.2 China National Biotec Business Overview
8.9.3 China National Biotec Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 China National Biotec Vaccines Product Portfolio
8.9.5 China National Biotec Recent Developments
8.10 Tiantan
8.10.1 Tiantan Comapny Information
8.10.2 Tiantan Business Overview
8.10.3 Tiantan Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Tiantan Vaccines Product Portfolio
8.10.5 Tiantan Recent Developments
8.11 Hualan
8.11.1 Hualan Comapny Information
8.11.2 Hualan Business Overview
8.11.3 Hualan Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Hualan Vaccines Product Portfolio
8.11.5 Hualan Recent Developments
8.12 Kangtai
8.12.1 Kangtai Comapny Information
8.12.2 Kangtai Business Overview
8.12.3 Kangtai Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Kangtai Vaccines Product Portfolio
8.12.5 Kangtai Recent Developments
8.13 Hissen
8.13.1 Hissen Comapny Information
8.13.2 Hissen Business Overview
8.13.3 Hissen Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Hissen Vaccines Product Portfolio
8.13.5 Hissen Recent Developments
8.14 Jintan
8.14.1 Jintan Comapny Information
8.14.2 Jintan Business Overview
8.14.3 Jintan Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Jintan Vaccines Product Portfolio
8.14.5 Jintan Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Vaccines Value Chain Analysis
9.1.1 Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Vaccines Production Mode & Process
9.2 Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Vaccines Distributors
9.2.3 Vaccines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings